AU5550700A - Novel process - Google Patents

Novel process

Info

Publication number
AU5550700A
AU5550700A AU55507/00A AU5550700A AU5550700A AU 5550700 A AU5550700 A AU 5550700A AU 55507/00 A AU55507/00 A AU 55507/00A AU 5550700 A AU5550700 A AU 5550700A AU 5550700 A AU5550700 A AU 5550700A
Authority
AU
Australia
Prior art keywords
novel process
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55507/00A
Inventor
Andrew Simon Craig
Victor Witold Jacewicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU5550700A publication Critical patent/AU5550700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU55507/00A 1999-06-22 2000-06-22 Novel process Abandoned AU5550700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9914600 1999-06-22
GBGB9914600.3A GB9914600D0 (en) 1999-06-22 1999-06-22 Novel,process
PCT/GB2000/002421 WO2000078288A2 (en) 1999-06-22 2000-06-22 Novel process for paroxetine compositions

Publications (1)

Publication Number Publication Date
AU5550700A true AU5550700A (en) 2001-01-09

Family

ID=10855850

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55507/00A Abandoned AU5550700A (en) 1999-06-22 2000-06-22 Novel process

Country Status (3)

Country Link
AU (1) AU5550700A (en)
GB (1) GB9914600D0 (en)
WO (1) WO2000078288A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
EP1313474A2 (en) * 2000-08-28 2003-05-28 Synthon B.V. Paroxetine compositions and processes for making the same
DK200100341A (en) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Process for the preparation of pharmaceutical tablets containing paroxetine hydrochloride anhydrate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
US6638948B1 (en) * 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
AU730532B2 (en) * 1997-01-15 2001-03-08 Smithkline Beecham Plc Paroxetine compositions
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations

Also Published As

Publication number Publication date
GB9914600D0 (en) 1999-08-25
WO2000078288A3 (en) 2001-02-15
WO2000078288A2 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
AU1854901A (en) Novel method
AU1538901A (en) Polymersation process
GB9920917D0 (en) Novel process
AU1038501A (en) Novel processes
AU7273000A (en) Novel processes
AU2359301A (en) Novel ss-defensins
AU2207001A (en) Novel compounds and process
GB9914583D0 (en) Novel process
AU1165801A (en) Novel process
AU6169100A (en) Novel process
AU5550700A (en) Novel process
AU2757299A (en) Novel process
AU2290401A (en) Novel processes
AU5995900A (en) Novel process
AU5521800A (en) Novel process
AU5694600A (en) Novel process
AU7510100A (en) Novel process
AU2985200A (en) Novel sialoadhesins
GB9920147D0 (en) Novel process
AU4323400A (en) Novel process
AUPQ249799A0 (en) An interaction process
AUPP934399A0 (en) Process
AUPQ215899A0 (en) Hydroboronation process
AU5675000A (en) Process
GB9919001D0 (en) Novel process

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase